Last edition
News about
As part of the collaboration, Bayer will further develop its innovation platform to accelerate the development and deployment of AI-powered healthcare applications with a clear focus on radiology, using Google Cloud's technology, including its generative AI (gen AI) tools.
FDA Grants Seven-Year Exclusivity to RADICAVA ORS for ALS Treatment
This recognition highlights the FDA's acknowledgment of the oral form of edaravone as a crucial advancement for ALS patients, providing a more accessible treatment option.
Ayana Pharma Signs Five Year MSA with Scinai Bioservices for Drug Development
Scinai Immunotherapeutics Ltd. has announced that Ayana Pharma Ltd. signed a five-year Master Service Agreement (MSA) with the company's CDMO business unit, Scinai Bioservices.
FDA Approves Onkos Surgical's Antibacterial Implants to Combat Orthopedic Contamination
A comprehensive body of preclinical safety and efficacy data substantiated the De Novo application.
Eaton to Showcase New Filtration Solutions for Liquids at ACHEMA 2024
Eaton has announced that the company will be exhibiting numerous new filtration solutions for the Industrial Processing, Life Sciences, and Hydraulic Filtration segments.
Merck India Welcomes Dhananjay Singh as New MD of Life Science in India
Merck, a science and technology company, has appointed Dhananjay Singh as the Managing Director of Merck Life Science in India.
Pharming Completes Enrollment in Pediatric Clinical Trial of leniolisib
Pharming Group has recently completed patient enrollment in its Phase III clinical trial (NCT05438407) evaluating the investigational drug leniolisib.
Indigenously Developed CAR T-Cell Therapy Launched for Cancer Treatment in India
President Droupadi Murmu has rolled out India’s first indigenously-developed CAR T-cell therapy for the treatment of cancer.
Lupin Gains Approval from FDA for Valbenazine Capsules
Lupin Ltd. has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Valbenazine Capsules.
Rebound Medical Receives Growth Equity Investment from Castleford Capital
Rebound provides durable medical equipment to patients recovering from orthopedic and vascular surgical procedures.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy